Tumor Course Faculty – 2023
Course Director
Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Radiation Oncology (Tumor Biology), Harvard Medical School; Director, E.L. Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
Faculty
George Coukos, M.D., Ph.D., Professor; Director of Hi-TIDe - Human integrated tumor immunology discovery engine; Head of the Department of oncology; Department of oncology UNIL CHUV, Ludwig Institute for Cancer Research, Lausanne, Switzerland
Lisa M. Coussens, Ph.D., Hildegard Lamfrom Chair in Basic Science; Professor and Chair, Cell and Developmental Biology; Associate Director for Basic Research, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
Gordon J. Freeman, PhD, Professor, Department of Medical Oncology, Dana-Farber Cancer Institute and Professor of Medicine, Harvard Medical School
Chi Van Dang, M.D., Ph.D., Scientific director, Ludwig Institute for Cancer Research; Professor, Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA, USA
Nir Hacohen, Ph.D., Director, Massachusetts General Hospital Center for Cancer Immunotherapy, Member, Broad Institute, Boston, MA, USA
Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Tumor Biology, Harvard Medical School; Director, E.L. Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
Carl H. June, M.D., Richard W. Vague Professor in Immunotherapy, Department of Pathology and Laboratory Medicine; Director of the Center for Cellular Immunotherapies; Director of the Parker Institute for Cancer Immunotherapy; University of Pennsylvania, Philadelphia, PA, USA
George W. Sledge, Jr., M.D., Professor of Medicine and Chief, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA
Mario L. Suva, M.D., Ph.D., Associate Professor of Pathology, Massachusetts General Hospital and Harvard Medical School Associate Member at the Broad Institute of MIT and Harvard, Co-Director, Cancer Program, Harvard Stem Cell Institute, Boston, MA, USA
Michael D. Taylor, M.D., Ph.D., F.R.C.S., Principal Investigator, The Arthur and Sonia Labatt Brain Tumour Research Centre; Senior Scientist, Developmental & Stem Cell Biology; Associate Professor, Departments of Surgery and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada
David A. Tuveson, M.D., Ph.D., Professor and Director, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA
Matthew Vander Heiden, M.D., Ph.D., Associate Professor of Biology, Massachusetts Institute of Technology; Associate Director, Koch Institute for Integrative Cancer Research, Cambridge, MA, USA
Jennifer A. Wargo, M.D., Professor, Surgical Oncology & Genomic Medicine; Program Director for PRIME TR, MD Anderson Cancer Center, Houston, TX, USA
Robert A. Weinberg, Ph.D., Daniel K. Ludwig Professor for Cancer Research at Massachusetts Institute of Technology, Director of the Ludwig Center of the MIT, and American Cancer Society Research Professor